anayamalik, Author at European Medical Journal - Page 68 of 97

Mechanical Ventilation Elevates AKI Risk in ICU

The association between invasive mechanical ventilation (IMV) and an increased risk of acute kidney injury (AKI) in critically ill patients, with a notable impact on those diagnosed with COVID-19, has been investigated in a recent multicenter study.

Infectious Diseases Experts to Lead The Charge in Healthcare Sustainability

A review article highlights the urgent need for healthcare professionals, particularly those in infectious diseases, to take action in reducing the sector’s substantial environmental impact.

Sex and Age Play Key Role in Pyogenic Granuloma Incidence

A new retrospective study has shed light on the incidence of cutaneous pyogenic granulomas (PGs) by age, sex, and anatomical location.

Apixaban Linked to Fewer Covert Infarcts Post-Stroke

Apixaban has been shown to reduce the risk of nonlacunar covert infarcts in patients who have experienced a recent cryptogenic stroke and have atrial cardiopathy.

Lung Cancer Risk Factors Shifting in 10 Largest Countries

Lung cancer remains one of the deadliest diseases worldwide, with changing risk factors influencing mortality rates.

Understanding Pain in Adults with Cystic Fibrosis

Pain in adults with cystic fibrosis (CF) has long been underrecognized, and a new study reveals troubling insights into its prevalence and management.

COVID-19 Overtakes Flu and RSV in Long-Term Mortality Risk

Over 141,000 nonhospitalized U.S. veterans were included in a new study that has provided new insights into the relative severity and long-term mortality associated with SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).

Ketogenic Diet May Exacerbate Osteoarthritis and Pain

A ketogenic diet (KD) may worsen osteoarthritis (OA) severity and increase pain sensitivity according to the results of a new study.

Functional Biomarkers: A New Tool in Melanoma Immunotherapy

Understanding why some patients with melanoma respond to immunotherapy while others do not has remained a critical challenge for precision medicine.

Innovative Approach Enhances Outcomes in Metastatic NSCLC

A recent multicenter Phase II trial has demonstrated that combining chemoradiotherapy (CRT) with aggressive local consolidative therapy (LCT) can improve survival rates in patients with Stage IV non-small cell lung carcinoma (NSCLC) presenting with oligometastases.